$Refractal$

Refractal Information

PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.

Website	http://www.refractal.com
Revenue	$4.4 million
Employees	2 (0 on RocketReach)
Founded	2017
Address	329 Oyster Point Blvd FL 3, South San Francisco, California 94080, US
Phone	+1 978-777-5500
Industry	Wellness and Fitness Services, Business Services General, Business Services
Keywords	Viral Detection, Sensor Technology, Sars Cov 2 Testing, Sensor Platform, Protein Detection, Infectious Disease, Virus Testing, Biomarker Detection, Disease Diagnostics, Molecular Diagnostics, Diagnostic Platform, Rapid Diagnostics, High Throughput Screening, Healthcare Technology, Medical Diagnostics, Immunology Research, Point Of Care Diagnostics, Biotechnology, Precision Medicine
Competitors	Amazon, Microsoft, Google, Cloudflare, Akamai Technologies, Fastly +40 more (view full list)
SIC	SIC Code 5944 Companies, SIC Code 594 Companies, SIC Code 738 Companies, SIC Code 73 Companies, SIC Code 59 Companies
NAICS	NAICS Code 54 Companies, NAICS Code 44831 Companies, NAICS Code 541 Companies, NAICS Code 448 Companies, NAICS Code 4483 Companies, NAICS Code 44 Companies